Follow
Edouard Alphandéry
Edouard Alphandéry
Nanobacterie ; Sorbonne Université
Verified email at upmc.fr - Homepage
Title
Cited by
Cited by
Year
Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy
E Alphandery, S Faure, O Seksek, F Guyot, I Chebbi
ACS nano 5 (8), 6279-6296, 2011
3392011
Applications of magnetosomes synthesized by magnetotactic bacteria in medicine
E Alphandéry
Frontiers in bioengineering and biotechnology 2, 5, 2014
1962014
Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic …
E Alphandéry, F Guyot, I Chebbi
International journal of pharmaceutics 434 (1-2), 444-452, 2012
1372012
Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review
E Alphandéry, I Chebbi, F Guyot, M Durand-Dubief
International Journal of Hyperthermia 29 (8), 801-809, 2013
1152013
Heat production by bacterial magnetosomes exposed to an oscillating magnetic field
E Alphandéry, S Faure, L Raison, E Duguet, PA Howse, DA Bazylinski
The Journal of Physical Chemistry C 115 (1), 18-22, 2011
1152011
Assemblies of aligned magnetotactic bacteria and extracted magnetosomes: what is the main factor responsible for the magnetic anisotropy?
E Alphandéry, Y Ding, AT Ngo, ZL Wang, LF Wu, MP Pileni
Acs Nano 3 (6), 1539-1547, 2009
1112009
Glioblastoma treatments: an account of recent industrial developments
E Alphandéry
Frontiers in pharmacology 9, 376931, 2018
1102018
Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma
R Le Fèvre, M Durand-Dubief, I Chebbi, C Mandawala, F Lagroix, ...
Theranostics 7 (18), 4618, 2017
1072017
Iron oxide nanoparticles for therapeutic applications
E Alphandéry
Drug discovery today 25 (1), 141-149, 2020
1062020
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
E Alphandéry, P Grand-Dewyse, R Lefèvre, C Mandawala, ...
Expert Review of anticancer therapy 15 (10), 1233-1255, 2015
1052015
Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease
E Alphandéry
Nanotoxicology 13 (5), 573-596, 2019
1022019
Self-assembled InSb quantum dots grown on GaSb: A Photoluminescence, magnetoluminescence and atomic force microscopy study
BZ E. Alphandéry, R. J. Nicholas, N. J. Mason, P. Möck, G. R. Booker
Appl. Phys. Lett. 74, 2041, 1999
1001999
Factors influencing the biosorption of gadolinium by micro-organisms and its mobilisation from sand
Y Andres, G Thouand, M Boualam, M Mergeay
Applied Microbiology and Biotechnology 54, 262-267, 2000
882000
Nano-therapies for glioblastoma treatment
E Alphandéry
Cancers 12 (1), 242, 2020
872020
Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using …
E Alphandéry, A Idbaih, C Adam, JY Delattre, C Schmitt, F Guyot, I Chebbi
Biomaterials 141, 210-222, 2017
802017
Natural metallic nanoparticles for application in nano-oncology
E Alphandéry
International Journal of Molecular Sciences 21 (12), 4412, 2020
762020
Perspectives of breast cancer thermotherapies
E Alphandéry
Journal of Cancer 5 (6), 472, 2014
622014
Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an …
E Alphandéry, A Idbaih, C Adam, JY Delattre, C Schmitt, F Guyot, I Chebbi
Journal of controlled release 262, 259-272, 2017
612017
Bio-synthesized iron oxide nanoparticles for cancer treatment
E Alphandéry
International journal of pharmaceutics 586, 119472, 2020
572020
Mass-dependent and-independent signature of Fe isotopes in magnetotactic bacteria
M Amor, V Busigny, P Louvat, A Gélabert, P Cartigny, M Durand-Dubief, ...
Science 352 (6286), 705-708, 2016
572016
The system can't perform the operation now. Try again later.
Articles 1–20